CombiMatrix Corp

Company Snapshot: CombiMatrix Corp

Last Change Volume High Low

Company Overview

CombiMatrix Corporation - Bought out -  provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at or by calling (800) 710-0624.

Client News

  1. Nov 10 2017 CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
  2. Nov 6 2017 CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
  3. Nov 2 2017 CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
  4. Nov 1 2017 Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
  5. Oct 20 2017 CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting